Navigation Links
Angiotech Pharmaceuticals, Inc. Announces Conference Call And Webcast
Date:4/16/2009

First Quarter 2009 Financial Results

VANCOUVER, April 16 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) will host a conference call discussing its financial results for the first quarter ended March 31, 2009, on Thursday April 30, 2009 at 11:00 AM ET (8:00 AM Pacific).

    Dial-in information for the earnings call on April 30, 2009 is as
    follows:
    North America (toll-free): (800) 901-5247
    International: (617) 786-4501
    Enter Passcode: 72734002

A live webcast of the earnings call will be available to interested parties through Angiotech's website at www.angiotech.com in the Investor Relations section.

A press release announcing Angiotech's financial results will be issued prior to the call on April 30 at approximately 8:00 AM ET (5:00 AM Pacific).

An archived replay of the call will be available until May 7, 2009.

    Replay information is as follows:
    North America (toll-free): (888) 286-8010
    International: (617) 801-6888
    Enter Passcode: 95526962

    About Angiotech Pharmaceuticals

Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company with over 1,500 dedicated employees. Angiotech discovers, develops and markets innovative treatment solutions for diseases or complications associated with medical device implants, surgical interventions and acute injury. To find out more about Angiotech (NASDAQ: ANPI, TSX: ANP), please visit our website at www.angiotech.com.


'/>"/>
SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Angiotech Pharmaceuticals, Inc. announces License Agreement with Baxter International Inc.
2. Angiotech announces positive results from Bio-Seal(TM) clinical study
3. Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008
4. Angiotech Pharmaceuticals, Inc. announces new Senior Secured Term Loan and Credit Facilities
5. Angiotech Pharmaceuticals announces time change of conference call and webcast
6. Angiotech announces termination of note purchase agreement with Ares Management and New Leaf Venture Partners
7. Angiotech Announces Webcast and Call-in Numbers for Annual and Special General Meeting of Shareholders
8. Angiotech Announces Extension of the Expiration Date of its Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014
9. Angiotech receives CE Mark approval of HemoStream(TM) Chronic Dialysis Catheter
10. Angiotech wins before the UK House of Lords
11. Angiotech to Establish Separate Operating and Royalty Businesses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ANNAPOLIS, Md. and GAITHERSBURG, ... Inc. (NYSE MKT: PIP) and Altimmune, Inc., a ... the signing of a definitive agreement for the ... transaction. Altimmune,s current investors include Novartis Venture Fund, ... company will be a fully-integrated and diversified immunotherapeutics ...
(Date:1/19/2017)... ... January 18, 2017 , ... LabRoots , ... from around the world, was today awarded the "Best Science & Technology Social ... on merit and decided upon by a dedicated team of researchers and analysts. ...
(Date:1/19/2017)... , Jan. 18, 2017  Northwest Biotherapeutics, Inc. (OTCQB: ... personalized immune therapies for operable and inoperable solid tumor ... Chief Technical Officer of NW Bio, will present at ... 2017, at the Hyatt Regency Hotel in ... chair the session entitled "New Therapeutic Approaches – Expanding ...
(Date:1/18/2017)... India , January 18, 2017 According to a ... (Cancer Diagnosis, Neuroscience, Cytology, Infectious Disease), & End User (Molecular Diagnostic Laboratories, Academic ... is expected to reach USD 739.9 Million by 2021 from USD 557.1 Million ... Continue Reading ... MarketsandMarkets Logo ...
Breaking Biology Technology:
(Date:1/12/2017)... NEW YORK , Jan. 12, 2017  New research ... around the office of the future.  1,000 participants were simply ... last three months which we may consider standard issue.  Insights ... office of 2017 were also gathered from futurists and industry ... and Dr. James Canton .  Some ...
(Date:1/6/2017)... Calif. , Jan. 6, 2017  Privately-held ... safety studies in healthy volunteers of a novel ... to treat acute pancreatitis. Acute ... typically a mild disorder, but can be very ... failure and sepsis, where extended hospital stays, time ...
(Date:1/4/2017)... 4, 2017  CES 2017 – Valencell , ... today announced the launch of two new versions ... highly-accurate biometric sensor modules that incorporate the best ... and expertise. The two new designs include Benchmark ... hearables, and Benchmark BW2.0, a 2-LED version of ...
Breaking Biology News(10 mins):